Concepedia

Francesca Carchesio

FC

Statistics

Publications

6

Citations

116

H-Index

6

Active since

2018

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Agostino Gemelli University Polyclinic

Università Cattolica del Sacro Cuore

Asklepios Klinik Altona

Semmelweis University

Francesca Carchesio is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in oncology, medicine, and interventional oncology.

Publications per year

2018–2022

6

Publications

6

TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib

Roberto Iezzi, Maurizio Pompili, Emanuele Rinninella et al. · European Radiology · 2018 · 39 citations

, , +4

The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis

Philippe L. Pereira, Roberto Iezzi, Riccardo Manfredi et al. · CardioVascular and Interventional Radiology · 2020 · 21 citations · Full text

, , +16

Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?

Roberto Iezzi, Maurizio Pompili, Alessandro Posa et al. · European Journal of Radiology · 2019 · 17 citations

, , +14

Critical review of multidisciplinary non-surgical local interventional ablation techniques in primary or secondary liver malignancies

Attila Kovács, Roberto Iezzi, Francesco Cellini et al. · Journal of Contemporary Brachytherapy · 2019 · 14 citations · Full text

, , +15

Safety, Feasibility and Technical Considerations from a Prospective, Observational Study—CIREL: Irinotecan-TACE for CRLM in 152 Patients

Thomas Helmberger, Pierleone Lucatelli, Philippe L. Pereira et al. · Journal of Clinical Medicine · 2022 · 13 citations · Full text

, , +17

1–5 of 6